# PharmaEste

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pharmaeste

- Industry: Biotechnology
- Headquarters: Italy
- Website: www.pharmeste.com
- Total disclosed funding: $19M
- Latest round: Series B (Jun 1, 2011)
- Investors on record: 8

## About

Founded in 2003 and is based in Italy, PharmaEste is a biopharmaceutical company, focuses on the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases.

## Funding rounds

- Series B, Jun 1, 2011, $6.9M — Xyence Capital, Value Italy, META Group, MP Healthcare Venture Management, Z-Cube, Mitsubishi Tanabe Group, Mitsubishi Chemical Holdings Corporation
- Series B, Oct 2, 2008, $8.4M — Xyence Capital, Value Italy, Z-Cube, Mitsubishi Tanabe Group
- Series A, Jan 1, 2007, $3.2M — Green Arrow Capital, Xyence Capital, META Group, Z-Cube

## Investors

- Green Arrow Capital (https://capitalatlas.ai/funds/green-arrow-capital) — Series A
- Xyence Capital (https://capitalatlas.ai/funds/xyence-capital) — Series A, Series B
- META Group (https://capitalatlas.ai/funds/meta-group) — Series A, Series B
- Z-Cube — Series A, Series B
- Value Italy (https://capitalatlas.ai/funds/value-italy) — Series B
- Mitsubishi Tanabe Group — Series B
- MP Healthcare Venture Management (https://capitalatlas.ai/funds/mp-healthcare-venture-management) — Series B
- Mitsubishi Chemical Holdings Corporation — Series B